Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,330 | 340 | 99.0% |
| Consulting Fee | $150.00 | 1 | 0.8% |
| Education | $36.86 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,053 | 59 | $0 (2024) |
| Amgen Inc. | $2,754 | 39 | $0 (2024) |
| Lilly USA, LLC | $2,089 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,023 | 50 | $0 (2023) |
| Novo Nordisk Inc | $1,878 | 38 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,262 | 25 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $949.35 | 10 | $0 (2019) |
| PFIZER INC. | $679.67 | 16 | $0 (2024) |
| Gilead Sciences, Inc. | $661.67 | 6 | $0 (2020) |
| Indivior Inc. | $533.84 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.49 | 7 | Amgen Inc. ($141.79) |
| 2023 | $728.37 | 19 | Lilly USA, LLC ($272.24) |
| 2022 | $1,059 | 29 | Lilly USA, LLC ($262.63) |
| 2021 | $1,933 | 55 | AstraZeneca Pharmaceuticals LP ($719.29) |
| 2020 | $1,110 | 34 | Lilly USA, LLC ($286.21) |
| 2019 | $4,346 | 59 | AstraZeneca Pharmaceuticals LP ($863.23) |
| 2018 | $4,892 | 64 | AstraZeneca Pharmaceuticals LP ($1,118) |
| 2017 | $5,118 | 79 | Merck Sharp & Dohme Corporation ($691.07) |
All Payment Transactions
346 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/01/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Inflammation | ||||||
| 01/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Opioid Use Disorder | ||||||
| 10/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $116.17 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Respiratory | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Respiratory | ||||||
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 07/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Respiratory | ||||||
| 07/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: DIABETES | ||||||
| 04/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 04/03/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Respiratory | ||||||
| 03/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes | ||||||
| 01/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 01/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 364 | 934 | $103,305 | $51,310 |
| 2022 | 12 | 430 | 995 | $102,720 | $51,699 |
| 2021 | 12 | 518 | 1,248 | $98,235 | $55,006 |
| 2020 | 12 | 519 | 1,397 | $107,160 | $48,419 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 554 | $72,020 | $33,979 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 62 | 62 | $12,400 | $7,912 | 63.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 48 | $8,640 | $3,951 | 45.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 50 | $3,750 | $2,113 | 56.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,120 | $875.00 | 78.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 98 | $980.00 | $806.40 | 82.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 16 | $1,700 | $790.86 | 46.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 21 | 21 | $525.00 | $438.00 | 83.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 40 | $2,000 | $354.72 | 17.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 17 | $170.00 | $90.68 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 543 | $70,590 | $33,291 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $13,000 | $8,712 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 45 | $7,550 | $4,210 | 55.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 49 | $3,675 | $1,891 | 51.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,360 | $1,016 | 74.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 19 | 24 | $1,440 | $948.15 | 65.8% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 17 | 17 | $595.00 | $479.52 | 80.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 60 | 115 | $1,150 | $338.16 | 29.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $400.00 | $337.44 | 84.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 32 | 36 | $1,800 | $327.53 | 18.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 26 | $910.00 | $132.24 | 14.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 15 | 25 | $250.00 | $16.40 | 6.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 549 | $65,295 | $36,579 | 56.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 55 | 55 | $7,760 | $7,371 | 95.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 46 | $7,130 | $3,613 | 50.7% |
About Dr. Imad George, M.D
Dr. Imad George, M.D is a Internal Medicine healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346230182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imad George, M.D has received a total of $19,517 in payments from pharmaceutical and medical device companies, with $330.49 received in 2024. These payments were reported across 346 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($19,330).
As a Medicare-enrolled provider, George has provided services to 1,831 Medicare beneficiaries, totaling 4,574 services with total Medicare billing of $206,434. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Addiction Medicine
- Location Livonia, MI
- Active Since 10/24/2005
- Last Updated 12/17/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346230182
Products in Payments
- FARXIGA (Drug) $2,696
- TRULICITY (Drug) $1,193
- JARDIANCE (Drug) $1,137
- Aimovig (Biological) $966.19
- BREZTRI (Drug) $732.81
- Repatha (Biological) $727.57
- Ozempic (Drug) $701.29
- Epclusa (Drug) $661.67
- TRELEGY ELLIPTA (Drug) $653.69
- SUBLOCADE (Drug) $533.84
- BELSOMRA (Drug) $509.29
- Victoza (Drug) $484.85
- Prolia (Biological) $448.45
- Zubsolv (Drug) $444.03
- MOUNJARO (Drug) $362.27
- Tresiba (Drug) $359.90
- NATPARA (Drug) $303.85
- EVENITY (Biological) $301.58
- INVOKANA (Drug) $298.91
- BYDUREON (Drug) $292.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Livonia
Gary Ferguson, M.d, M.D
Internal Medicine — Payments: $1.2M
Dr. Steven Katzman, D.o, D.O
Internal Medicine — Payments: $935,319
Dr. Jason Paris, M.d, M.D
Internal Medicine — Payments: $47,232
Ala Shuker, M.d, M.D
Internal Medicine — Payments: $24,416
Stephanie Diamond
Internal Medicine — Payments: $14,062
Ronald Barnett, Do, DO
Internal Medicine — Payments: $12,402